Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

ABO(H) blood groups and vascular disease: a systematic review and meta-analysis.

Wu O, Bayoumi N, Vickers MA, Clark P.

J Thromb Haemost. 2008 Jan;6(1):62-9. Epub 2007 Oct 25.

2.

ABO blood group and vascular disease: an update.

Dentali F, Sironi AP, Ageno W, Crestani S, Franchini M.

Semin Thromb Hemost. 2014 Feb;40(1):49-59. doi: 10.1055/s-0033-1363460. Epub 2013 Dec 31. Review.

PMID:
24381150
3.

ABO(H) blood groups and pre-eclampsia. A systematic review and meta-analysis.

Clark P, Wu O.

Thromb Haemost. 2008 Sep;100(3):469-74. Review.

PMID:
18766264
4.

ABO blood groups and thrombosis: a causal association, but is there value in screening?

Clark P, Wu O.

Future Cardiol. 2011 Mar;7(2):191-201. doi: 10.2217/fca.10.191. Review.

PMID:
21453026
5.

Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature.

Dentali F, Sironi AP, Ageno W, Turato S, Bonfanti C, Frattini F, Crestani S, Franchini M.

Semin Thromb Hemost. 2012 Jul;38(5):535-48. doi: 10.1055/s-0032-1315758. Epub 2012 Jun 27. Review.

PMID:
22740183
6.

ABO blood group and thrombotic vascular disease.

Franchini M, Mannucci PM.

Thromb Haemost. 2014 Dec;112(6):1103-9. doi: 10.1160/TH14-05-0457. Epub 2014 Sep 4. Review.

PMID:
25187297
7.

ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?

Jenkins PV, O'Donnell JS.

Transfusion. 2006 Oct;46(10):1836-44. Review.

PMID:
17002642
8.

Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.

Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Langhorne P, Brenkel I, Regan L, Greer I.

Health Technol Assess. 2006 Apr;10(11):1-110. Review.

9.

Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review.

van Schie MC, van Loon JE, de Maat MP, Leebeek FW.

J Thromb Haemost. 2011 May;9(5):899-908. doi: 10.1111/j.1538-7836.2011.04243.x. Review.

10.

Relative Risks of Thrombosis and Bleeding in Different ABO Blood Groups.

Franchini M, Lippi G.

Semin Thromb Hemost. 2016 Mar;42(2):112-7. doi: 10.1055/s-0035-1564832. Epub 2015 Dec 30. Review.

PMID:
26716497
11.

The relationship between ABO histo-blood group, factor VIII and von Willebrand factor.

O'Donnell J, Laffan MA.

Transfus Med. 2001 Aug;11(4):343-51. Review.

PMID:
11532189
12.

Relationship between ABO blood group and hemorrhage: a systematic literature review and meta-analysis.

Dentali F, Sironi AP, Ageno W, Bonfanti C, Crestani S, Frattini F, Steidl L, Franchini M.

Semin Thromb Hemost. 2013 Feb;39(1):72-82. doi: 10.1055/s-0032-1329550. Epub 2013 Jan 8. Review.

PMID:
23299820
13.

ABO blood group system and the coronary artery disease: an updated systematic review and meta-analysis.

Chen Z, Yang SH, Xu H, Li JJ.

Sci Rep. 2016 Mar 18;6:23250. doi: 10.1038/srep23250. Review.

14.

Is ABO blood group truly a risk factor for thrombosis and adverse outcomes?

Zhou S, Welsby I.

World J Cardiol. 2014 Sep 26;6(9):985-92. doi: 10.4330/wjc.v6.i9.985. Review.

15.

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.

Greenhalgh J, Bagust A, Boland A, Martin Saborido C, Oyee J, Blundell M, Dundar Y, Dickson R, Proudlove C, Fisher M.

Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310. Review.

16.

ABO blood group as a potential risk factor for venous thromboembolism in acutely injured patients.

Muellner SK, Haut ER, Streiff MB, Holcomb JB, Cotton BA.

Thromb Haemost. 2011 Jan;105(1):5-13. doi: 10.1160/TH10-08-0504. Epub 2010 Nov 23. Review.

PMID:
21103665
17.

ABO Blood Group as a Model for Platelet Glycan Modification in Arterial Thrombosis.

Zhong M, Zhang H, Reilly JP, Chrisitie JD, Ishihara M, Kumagai T, Azadi P, Reilly MP.

Arterioscler Thromb Vasc Biol. 2015 Jul;35(7):1570-8. doi: 10.1161/ATVBAHA.115.305337. Epub 2015 Jun 4. Review.

18.

ABO blood group and von Willebrand factor: biological implications.

Franchini M, Crestani S, Frattini F, Sissa C, Bonfanti C.

Clin Chem Lab Med. 2014 Sep;52(9):1273-6. doi: 10.1515/cclm-2014-0564. Review.

PMID:
24945431
19.

ABO blood group and ovarian reserve: a meta-analysis and systematic review.

Deng J, Jia M, Cheng X, Yan Z, Fan D, Tian X.

Oncotarget. 2017 Apr 11;8(15):25628-25636. doi: 10.18632/oncotarget.15759. Review.

20.

ABO blood group, hypercoagulability, and cardiovascular and cancer risk.

Franchini M, Favaloro EJ, Targher G, Lippi G.

Crit Rev Clin Lab Sci. 2012 Jul-Aug;49(4):137-49. doi: 10.3109/10408363.2012.708647. Epub 2012 Aug 3. Review.

PMID:
22856614

Supplemental Content

Support Center